Related Experiment Videos

Haemopoietic toxicity and low-dose methotrexate

G A McArthur, M F Cole-Sinclair, M B Van Der Weyden

The Medical Journal of Australia

|February 17, 1992

Summary

No abstract available in PubMed .

Related Concept Videos

Articles linked to this work by shared authors, journal, and citation graph.

Biomarkers of treatment benefit with atezolizumab plus vemurafenib plus cobimetinib in BRAF<sup>V600</sup> mutation-positive melanoma.

Annals of oncology : official journal of the European Society for Medical Oncology·2022

Prediction and monitoring of relapse in stage III melanoma using circulating tumor DNA.

Annals of oncology : official journal of the European Society for Medical Oncology·2019

Multiplex immunohistochemistry accurately defines the immune context of metastatic melanoma.

Scientific reports·2018

Surveillance imaging with FDG-PET/CT in the post-operative follow-up of stage 3 melanoma.

Annals of oncology : official journal of the European Society for Medical Oncology·2018

Vemurafenib in patients with BRAFV600 mutation-positive metastatic melanoma: final overall survival results of the randomized BRIM-3 study.

Annals of oncology : official journal of the European Society for Medical Oncology·2017

Incidence, course, and management of toxicities associated with cobimetinib in combination with vemurafenib in the coBRIM study.

Annals of oncology : official journal of the European Society for Medical Oncology·2017

See all related articles